Masson E A, Atkin S L, Diver M, White M C
Department of Endocrinology, Royal Liverpool University Hospital, UK.
Clin Endocrinol (Oxf). 1993 Jan;38(1):109-10. doi: 10.1111/j.1365-2265.1993.tb00980.x.
Pituitary apoplexy has been reported as a rare complication of combined tests and of TRH administration in prolactinomas. A 54-year-old man with a pituitary macroadenoma had a single injection of 100 micrograms GnRH. Twenty minutes later he complained of increasing headache and vomited. These symptoms settled spontaneously and were attributed to the pharmacological effects of GnRH. Five hours later he was found to be blind and disorientated without spontaneous complaint. Emergency CT showed a large adenoma with central necrosis, consistent with pituitary apoplexy. An urgent surgical decompression was carried out and necrotic haemorrhagic debris removed. Baseline bloods revealed non-pulsatile FSH of 40 U/l with LH 0.3 U/l with no hormonal response to GnRH administration, but the sequence of events strongly suggests a causal relationship between this and pituitary apoplexy. To our knowledge this is the first time that GnRH administration has been associated with pituitary apoplexy of a glycoprotein secreting pituitary adenoma.
垂体卒中已被报道为联合试验及在泌乳素瘤中给予促甲状腺激素释放激素(TRH)时的一种罕见并发症。一名患有垂体大腺瘤的54岁男性单次注射了100微克促性腺激素释放激素(GnRH)。20分钟后,他主诉头痛加剧并呕吐。这些症状自行缓解,被归因于GnRH的药理作用。5小时后,发现他失明且定向障碍,无自发主诉。急诊CT显示一个伴有中央坏死的大腺瘤,符合垂体卒中表现。进行了紧急手术减压并清除了坏死性出血性碎片。基础血液检查显示促卵泡生成素(FSH)非脉冲式水平为40 U/l,促黄体生成素(LH)为0.3 U/l,对GnRH给药无激素反应,但事件的先后顺序强烈提示这与垂体卒中之间存在因果关系。据我们所知,这是首次报道GnRH给药与分泌糖蛋白的垂体腺瘤的垂体卒中相关。